NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

Go back to NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: NXTC) Delayed: 5.67 -0.36 (5.97%)
Previous Close $6.03    52 Week High
Open $6.05    52 Week Low
Day High $6.38    P/E N/A 
Day Low $5.54    EPS
Volume 106,844